VBIV
VBI Vaccines IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.87M
P/E Ratio
—
EPS
$-3.54
Beta
2.17
52W High
$0.00
52W Low
$0.00
50-Day MA
$0.48
200-Day MA
$0.58
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About VBI Vaccines Inc
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company is headquartered in Cambridge, Massachusetts.
Fundamentals
| Revenue (TTM) | $9.41M |
| Gross Profit (TTM) | $-10.19M |
| EBITDA | $-45.58M |
| Operating Margin | -968.00% |
| Return on Equity | -419.60% |
| Return on Assets | -29.10% |
| Revenue/Share (TTM) | $0.48 |
| Book Value | $-0.22 |
| Price-to-Book | 1.24 |
| Price-to-Sales (TTM) | 0.20 |
| EV/Revenue | 4.105 |
| EV/EBITDA | -0.69 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 150.30% |
| Shares Outstanding | $28.68M |
| Float | $26.73M |
| % Insiders | 6.77% |
| % Institutions | 13.04% |
More HEALTHCARE Stocks
Data last updated: 5/2/2026